Q1 revenue -10% y-o-y, Q2 also likely to be soft, but we are approaching a recovery: activity level up 40% y-o-y. Valuation still demanding: reiterate HOLD.
Tough comps in Q4 as well, we estimate sales -9% y-o-y. We cut '24e-'25e EBIT by 10-14%. HOLD: Long-term outlook still strong, but tough short-term comps.